<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-03-01" modified="2024-10-02" version="205" xmlns="http://uniprot.org/uniprot">
  <accession>Q9HC16</accession>
  <accession>B2RDR9</accession>
  <accession>Q45F02</accession>
  <accession>Q5TF77</accession>
  <accession>Q7Z2N1</accession>
  <accession>Q7Z2N4</accession>
  <accession>Q9H9H8</accession>
  <name>ABC3G_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="57">DNA dC-&gt;dU-editing enzyme APOBEC-3G</fullName>
      <ecNumber evidence="4 21 25 26 46">3.5.4.38</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>APOBEC-related cytidine deaminase</fullName>
      <shortName>APOBEC-related protein</shortName>
      <shortName>ARCD</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>APOBEC-related protein 9</fullName>
      <shortName>ARP-9</shortName>
    </alternativeName>
    <alternativeName>
      <fullName evidence="53">CEM-15</fullName>
      <shortName evidence="53">CEM15</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>Deoxycytidine deaminase</fullName>
      <shortName evidence="56">A3G</shortName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="53 61" type="primary">APOBEC3G</name>
    <name type="ORF">MDS019</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="2003" name="J. Virol." volume="77" first="11398" last="11407">
      <title>The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.</title>
      <authorList>
        <person name="Kao S."/>
        <person name="Khan M.A."/>
        <person name="Miyagi E."/>
        <person name="Plishka R."/>
        <person name="Buckler-White A."/>
        <person name="Strebel K."/>
      </authorList>
      <dbReference type="PubMed" id="14557625"/>
      <dbReference type="DOI" id="10.1128/jvi.77.21.11398-11407.2003"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>FUNCTION IN HIV-1 INFECTION INHIBITION</scope>
    <source>
      <tissue>Kidney</tissue>
    </source>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
      <title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
      <authorList>
        <person name="Ota T."/>
        <person name="Suzuki Y."/>
        <person name="Nishikawa T."/>
        <person name="Otsuki T."/>
        <person name="Sugiyama T."/>
        <person name="Irie R."/>
        <person name="Wakamatsu A."/>
        <person name="Hayashi K."/>
        <person name="Sato H."/>
        <person name="Nagai K."/>
        <person name="Kimura K."/>
        <person name="Makita H."/>
        <person name="Sekine M."/>
        <person name="Obayashi M."/>
        <person name="Nishi T."/>
        <person name="Shibahara T."/>
        <person name="Tanaka T."/>
        <person name="Ishii S."/>
        <person name="Yamamoto J."/>
        <person name="Saito K."/>
        <person name="Kawai Y."/>
        <person name="Isono Y."/>
        <person name="Nakamura Y."/>
        <person name="Nagahari K."/>
        <person name="Murakami K."/>
        <person name="Yasuda T."/>
        <person name="Iwayanagi T."/>
        <person name="Wagatsuma M."/>
        <person name="Shiratori A."/>
        <person name="Sudo H."/>
        <person name="Hosoiri T."/>
        <person name="Kaku Y."/>
        <person name="Kodaira H."/>
        <person name="Kondo H."/>
        <person name="Sugawara M."/>
        <person name="Takahashi M."/>
        <person name="Kanda K."/>
        <person name="Yokoi T."/>
        <person name="Furuya T."/>
        <person name="Kikkawa E."/>
        <person name="Omura Y."/>
        <person name="Abe K."/>
        <person name="Kamihara K."/>
        <person name="Katsuta N."/>
        <person name="Sato K."/>
        <person name="Tanikawa M."/>
        <person name="Yamazaki M."/>
        <person name="Ninomiya K."/>
        <person name="Ishibashi T."/>
        <person name="Yamashita H."/>
        <person name="Murakawa K."/>
        <person name="Fujimori K."/>
        <person name="Tanai H."/>
        <person name="Kimata M."/>
        <person name="Watanabe M."/>
        <person name="Hiraoka S."/>
        <person name="Chiba Y."/>
        <person name="Ishida S."/>
        <person name="Ono Y."/>
        <person name="Takiguchi S."/>
        <person name="Watanabe S."/>
        <person name="Yosida M."/>
        <person name="Hotuta T."/>
        <person name="Kusano J."/>
        <person name="Kanehori K."/>
        <person name="Takahashi-Fujii A."/>
        <person name="Hara H."/>
        <person name="Tanase T.-O."/>
        <person name="Nomura Y."/>
        <person name="Togiya S."/>
        <person name="Komai F."/>
        <person name="Hara R."/>
        <person name="Takeuchi K."/>
        <person name="Arita M."/>
        <person name="Imose N."/>
        <person name="Musashino K."/>
        <person name="Yuuki H."/>
        <person name="Oshima A."/>
        <person name="Sasaki N."/>
        <person name="Aotsuka S."/>
        <person name="Yoshikawa Y."/>
        <person name="Matsunawa H."/>
        <person name="Ichihara T."/>
        <person name="Shiohata N."/>
        <person name="Sano S."/>
        <person name="Moriya S."/>
        <person name="Momiyama H."/>
        <person name="Satoh N."/>
        <person name="Takami S."/>
        <person name="Terashima Y."/>
        <person name="Suzuki O."/>
        <person name="Nakagawa S."/>
        <person name="Senoh A."/>
        <person name="Mizoguchi H."/>
        <person name="Goto Y."/>
        <person name="Shimizu F."/>
        <person name="Wakebe H."/>
        <person name="Hishigaki H."/>
        <person name="Watanabe T."/>
        <person name="Sugiyama A."/>
        <person name="Takemoto M."/>
        <person name="Kawakami B."/>
        <person name="Yamazaki M."/>
        <person name="Watanabe K."/>
        <person name="Kumagai A."/>
        <person name="Itakura S."/>
        <person name="Fukuzumi Y."/>
        <person name="Fujimori Y."/>
        <person name="Komiyama M."/>
        <person name="Tashiro H."/>
        <person name="Tanigami A."/>
        <person name="Fujiwara T."/>
        <person name="Ono T."/>
        <person name="Yamada K."/>
        <person name="Fujii Y."/>
        <person name="Ozaki K."/>
        <person name="Hirao M."/>
        <person name="Ohmori Y."/>
        <person name="Kawabata A."/>
        <person name="Hikiji T."/>
        <person name="Kobatake N."/>
        <person name="Inagaki H."/>
        <person name="Ikema Y."/>
        <person name="Okamoto S."/>
        <person name="Okitani R."/>
        <person name="Kawakami T."/>
        <person name="Noguchi S."/>
        <person name="Itoh T."/>
        <person name="Shigeta K."/>
        <person name="Senba T."/>
        <person name="Matsumura K."/>
        <person name="Nakajima Y."/>
        <person name="Mizuno T."/>
        <person name="Morinaga M."/>
        <person name="Sasaki M."/>
        <person name="Togashi T."/>
        <person name="Oyama M."/>
        <person name="Hata H."/>
        <person name="Watanabe M."/>
        <person name="Komatsu T."/>
        <person name="Mizushima-Sugano J."/>
        <person name="Satoh T."/>
        <person name="Shirai Y."/>
        <person name="Takahashi Y."/>
        <person name="Nakagawa K."/>
        <person name="Okumura K."/>
        <person name="Nagase T."/>
        <person name="Nomura N."/>
        <person name="Kikuchi H."/>
        <person name="Masuho Y."/>
        <person name="Yamashita R."/>
        <person name="Nakai K."/>
        <person name="Yada T."/>
        <person name="Nakamura Y."/>
        <person name="Ohara O."/>
        <person name="Isogai T."/>
        <person name="Sugano S."/>
      </authorList>
      <dbReference type="PubMed" id="14702039"/>
      <dbReference type="DOI" id="10.1038/ng1285"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Synovium</tissue>
      <tissue>Teratocarcinoma</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="submission" date="1999-09" db="EMBL/GenBank/DDBJ databases">
      <title>Novel genes expressed in hematopoietic stem/progenitor cells from myelodysplastic syndrome patients.</title>
      <authorList>
        <person name="Huang C."/>
        <person name="Qian B."/>
        <person name="Tu Y."/>
        <person name="Gu W."/>
        <person name="Wang Y."/>
        <person name="Han Z."/>
        <person name="Chen Z."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Hematopoietic stem cell</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
      <title>A genome annotation-driven approach to cloning the human ORFeome.</title>
      <authorList>
        <person name="Collins J.E."/>
        <person name="Wright C.L."/>
        <person name="Edwards C.A."/>
        <person name="Davis M.P."/>
        <person name="Grinham J.A."/>
        <person name="Cole C.G."/>
        <person name="Goward M.E."/>
        <person name="Aguado B."/>
        <person name="Mallya M."/>
        <person name="Mokrab Y."/>
        <person name="Huckle E.J."/>
        <person name="Beare D.M."/>
        <person name="Dunham I."/>
      </authorList>
      <dbReference type="PubMed" id="15461802"/>
      <dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
  </reference>
  <reference key="5">
    <citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <consortium name="SeattleSNPs program for genomic applications"/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>VARIANTS ARG-186 AND GLU-275</scope>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
      <title>The DNA sequence of human chromosome 22.</title>
      <authorList>
        <person name="Dunham I."/>
        <person name="Hunt A.R."/>
        <person name="Collins J.E."/>
        <person name="Bruskiewich R."/>
        <person name="Beare D.M."/>
        <person name="Clamp M."/>
        <person name="Smink L.J."/>
        <person name="Ainscough R."/>
        <person name="Almeida J.P."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C."/>
        <person name="Bailey J."/>
        <person name="Barlow K.F."/>
        <person name="Bates K.N."/>
        <person name="Beasley O.P."/>
        <person name="Bird C.P."/>
        <person name="Blakey S.E."/>
        <person name="Bridgeman A.M."/>
        <person name="Buck D."/>
        <person name="Burgess J."/>
        <person name="Burrill W.D."/>
        <person name="Burton J."/>
        <person name="Carder C."/>
        <person name="Carter N.P."/>
        <person name="Chen Y."/>
        <person name="Clark G."/>
        <person name="Clegg S.M."/>
        <person name="Cobley V.E."/>
        <person name="Cole C.G."/>
        <person name="Collier R.E."/>
        <person name="Connor R."/>
        <person name="Conroy D."/>
        <person name="Corby N.R."/>
        <person name="Coville G.J."/>
        <person name="Cox A.V."/>
        <person name="Davis J."/>
        <person name="Dawson E."/>
        <person name="Dhami P.D."/>
        <person name="Dockree C."/>
        <person name="Dodsworth S.J."/>
        <person name="Durbin R.M."/>
        <person name="Ellington A.G."/>
        <person name="Evans K.L."/>
        <person name="Fey J.M."/>
        <person name="Fleming K."/>
        <person name="French L."/>
        <person name="Garner A.A."/>
        <person name="Gilbert J.G.R."/>
        <person name="Goward M.E."/>
        <person name="Grafham D.V."/>
        <person name="Griffiths M.N.D."/>
        <person name="Hall C."/>
        <person name="Hall R.E."/>
        <person name="Hall-Tamlyn G."/>
        <person name="Heathcott R.W."/>
        <person name="Ho S."/>
        <person name="Holmes S."/>
        <person name="Hunt S.E."/>
        <person name="Jones M.C."/>
        <person name="Kershaw J."/>
        <person name="Kimberley A.M."/>
        <person name="King A."/>
        <person name="Laird G.K."/>
        <person name="Langford C.F."/>
        <person name="Leversha M.A."/>
        <person name="Lloyd C."/>
        <person name="Lloyd D.M."/>
        <person name="Martyn I.D."/>
        <person name="Mashreghi-Mohammadi M."/>
        <person name="Matthews L.H."/>
        <person name="Mccann O.T."/>
        <person name="Mcclay J."/>
        <person name="Mclaren S."/>
        <person name="McMurray A.A."/>
        <person name="Milne S.A."/>
        <person name="Mortimore B.J."/>
        <person name="Odell C.N."/>
        <person name="Pavitt R."/>
        <person name="Pearce A.V."/>
        <person name="Pearson D."/>
        <person name="Phillimore B.J.C.T."/>
        <person name="Phillips S.H."/>
        <person name="Plumb R.W."/>
        <person name="Ramsay H."/>
        <person name="Ramsey Y."/>
        <person name="Rogers L."/>
        <person name="Ross M.T."/>
        <person name="Scott C.E."/>
        <person name="Sehra H.K."/>
        <person name="Skuce C.D."/>
        <person name="Smalley S."/>
        <person name="Smith M.L."/>
        <person name="Soderlund C."/>
        <person name="Spragon L."/>
        <person name="Steward C.A."/>
        <person name="Sulston J.E."/>
        <person name="Swann R.M."/>
        <person name="Vaudin M."/>
        <person name="Wall M."/>
        <person name="Wallis J.M."/>
        <person name="Whiteley M.N."/>
        <person name="Willey D.L."/>
        <person name="Williams L."/>
        <person name="Williams S.A."/>
        <person name="Williamson H."/>
        <person name="Wilmer T.E."/>
        <person name="Wilming L."/>
        <person name="Wright C.L."/>
        <person name="Hubbard T."/>
        <person name="Bentley D.R."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Shimizu N."/>
        <person name="Minoshima S."/>
        <person name="Kawasaki K."/>
        <person name="Sasaki T."/>
        <person name="Asakawa S."/>
        <person name="Kudoh J."/>
        <person name="Shintani A."/>
        <person name="Shibuya K."/>
        <person name="Yoshizaki Y."/>
        <person name="Aoki N."/>
        <person name="Mitsuyama S."/>
        <person name="Roe B.A."/>
        <person name="Chen F."/>
        <person name="Chu L."/>
        <person name="Crabtree J."/>
        <person name="Deschamps S."/>
        <person name="Do A."/>
        <person name="Do T."/>
        <person name="Dorman A."/>
        <person name="Fang F."/>
        <person name="Fu Y."/>
        <person name="Hu P."/>
        <person name="Hua A."/>
        <person name="Kenton S."/>
        <person name="Lai H."/>
        <person name="Lao H.I."/>
        <person name="Lewis J."/>
        <person name="Lewis S."/>
        <person name="Lin S.-P."/>
        <person name="Loh P."/>
        <person name="Malaj E."/>
        <person name="Nguyen T."/>
        <person name="Pan H."/>
        <person name="Phan S."/>
        <person name="Qi S."/>
        <person name="Qian Y."/>
        <person name="Ray L."/>
        <person name="Ren Q."/>
        <person name="Shaull S."/>
        <person name="Sloan D."/>
        <person name="Song L."/>
        <person name="Wang Q."/>
        <person name="Wang Y."/>
        <person name="Wang Z."/>
        <person name="White J."/>
        <person name="Willingham D."/>
        <person name="Wu H."/>
        <person name="Yao Z."/>
        <person name="Zhan M."/>
        <person name="Zhang G."/>
        <person name="Chissoe S."/>
        <person name="Murray J."/>
        <person name="Miller N."/>
        <person name="Minx P."/>
        <person name="Fulton R."/>
        <person name="Johnson D."/>
        <person name="Bemis G."/>
        <person name="Bentley D."/>
        <person name="Bradshaw H."/>
        <person name="Bourne S."/>
        <person name="Cordes M."/>
        <person name="Du Z."/>
        <person name="Fulton L."/>
        <person name="Goela D."/>
        <person name="Graves T."/>
        <person name="Hawkins J."/>
        <person name="Hinds K."/>
        <person name="Kemp K."/>
        <person name="Latreille P."/>
        <person name="Layman D."/>
        <person name="Ozersky P."/>
        <person name="Rohlfing T."/>
        <person name="Scheet P."/>
        <person name="Walker C."/>
        <person name="Wamsley A."/>
        <person name="Wohldmann P."/>
        <person name="Pepin K."/>
        <person name="Nelson J."/>
        <person name="Korf I."/>
        <person name="Bedell J.A."/>
        <person name="Hillier L.W."/>
        <person name="Mardis E."/>
        <person name="Waterston R."/>
        <person name="Wilson R."/>
        <person name="Emanuel B.S."/>
        <person name="Shaikh T."/>
        <person name="Kurahashi H."/>
        <person name="Saitta S."/>
        <person name="Budarf M.L."/>
        <person name="McDermid H.E."/>
        <person name="Johnson A."/>
        <person name="Wong A.C.C."/>
        <person name="Morrow B.E."/>
        <person name="Edelmann L."/>
        <person name="Kim U.J."/>
        <person name="Shizuya H."/>
        <person name="Simon M.I."/>
        <person name="Dumanski J.P."/>
        <person name="Peyrard M."/>
        <person name="Kedra D."/>
        <person name="Seroussi E."/>
        <person name="Fransson I."/>
        <person name="Tapia I."/>
        <person name="Bruder C.E."/>
        <person name="O'Brien K.P."/>
        <person name="Wilkinson P."/>
        <person name="Bodenteich A."/>
        <person name="Hartman K."/>
        <person name="Hu X."/>
        <person name="Khan A.S."/>
        <person name="Lane L."/>
        <person name="Tilahun Y."/>
        <person name="Wright H."/>
      </authorList>
      <dbReference type="PubMed" id="10591208"/>
      <dbReference type="DOI" id="10.1038/990031"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="7">
    <citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3)</scope>
    <source>
      <tissue>Skin</tissue>
      <tissue>Uterus</tissue>
    </source>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2002" name="Genomics" volume="79" first="285" last="296">
      <title>An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.</title>
      <authorList>
        <person name="Jarmuz A."/>
        <person name="Chester A."/>
        <person name="Bayliss J."/>
        <person name="Gisbourne J."/>
        <person name="Dunham I."/>
        <person name="Scott J."/>
        <person name="Navaratnam N."/>
      </authorList>
      <dbReference type="PubMed" id="11863358"/>
      <dbReference type="DOI" id="10.1006/geno.2002.6718"/>
    </citation>
    <scope>GENE FAMILY ORGANIZATION</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>SUBUNIT</scope>
    <scope>RNA-BINDING</scope>
    <scope>ZINC-BINDING</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2002" name="Nature" volume="418" first="646" last="650">
      <title>Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.</title>
      <authorList>
        <person name="Sheehy A.M."/>
        <person name="Gaddis N.C."/>
        <person name="Choi J.D."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="12167863"/>
      <dbReference type="DOI" id="10.1038/nature00939"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>FUNCTION IN HIV-1 INFECTION INHIBITION</scope>
    <source>
      <tissue>T-cell lymphoma</tissue>
    </source>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2003" name="Nature" volume="424" first="99" last="103">
      <title>Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.</title>
      <authorList>
        <person name="Mangeat B."/>
        <person name="Turelli P."/>
        <person name="Caron G."/>
        <person name="Friedli M."/>
        <person name="Perrin L."/>
        <person name="Trono D."/>
      </authorList>
      <dbReference type="PubMed" id="12808466"/>
      <dbReference type="DOI" id="10.1038/nature01709"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>FUNCTION IN DNA C TO U EDITING</scope>
    <scope>MUTAGENESIS OF GLU-67; HIS-81; GLU-85; CYS-97; CYS-100; CYS-221; HIS-257; GLU-259; CYS-288; CYS-291 AND GLU-323</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2003" name="Cell" volume="113" first="803" last="809">
      <title>DNA deamination mediates innate immunity to retroviral infection.</title>
      <authorList>
        <person name="Harris R.S."/>
        <person name="Bishop K.N."/>
        <person name="Sheehy A.M."/>
        <person name="Craig H.M."/>
        <person name="Petersen-Mahrt S.K."/>
        <person name="Watt I.N."/>
        <person name="Neuberger M.S."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="12809610"/>
      <dbReference type="DOI" id="10.1016/s0092-8674(03)00423-9"/>
    </citation>
    <scope>FUNCTION IN DNA C TO U EDITING</scope>
    <scope>MLV INFECTION INHIBITION</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2003" name="Nature" volume="424" first="94" last="98">
      <title>The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.</title>
      <authorList>
        <person name="Zhang H."/>
        <person name="Yang B."/>
        <person name="Pomerantz R.J."/>
        <person name="Zhang C."/>
        <person name="Arunachalam S.C."/>
        <person name="Gao L."/>
      </authorList>
      <dbReference type="PubMed" id="12808465"/>
      <dbReference type="DOI" id="10.1038/nature01707"/>
    </citation>
    <scope>FUNCTION IN DNA C TO U EDITING</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>COFACTOR</scope>
    <scope>MUTAGENESIS OF HIS-81; CYS-97; CYS-100; HIS-257; CYS-288 AND CYS-291</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2003" name="Cell" volume="114" first="21" last="31">
      <title>Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.</title>
      <authorList>
        <person name="Mariani R."/>
        <person name="Chen D."/>
        <person name="Schroefelbauer B."/>
        <person name="Navarro F."/>
        <person name="Koenig R."/>
        <person name="Bollman B."/>
        <person name="Muenk C."/>
        <person name="Nymark-McMahon H."/>
        <person name="Landau N.R."/>
      </authorList>
      <dbReference type="PubMed" id="12859895"/>
      <dbReference type="DOI" id="10.1016/s0092-8674(03)00515-4"/>
    </citation>
    <scope>FUNCTION IN DNA C TO U EDITING</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH HIV-1 PROTEIN VIF (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="44412" last="44416">
      <title>The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.</title>
      <authorList>
        <person name="Shindo K."/>
        <person name="Takaori-Kondo A."/>
        <person name="Kobayashi M."/>
        <person name="Abudu A."/>
        <person name="Fukunaga K."/>
        <person name="Uchiyama T."/>
      </authorList>
      <dbReference type="PubMed" id="12970355"/>
      <dbReference type="DOI" id="10.1074/jbc.c300376200"/>
    </citation>
    <scope>FUNCTION IN DNA C TO U EDITING</scope>
    <scope>INFECTION REGULATION OF HIV-1</scope>
    <scope>MUTAGENESIS OF GLU-67; CYS-100; GLU-259 AND CYS-291</scope>
    <source>
      <tissue>T-cell lymphoma</tissue>
    </source>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="591" last="601">
      <title>HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.</title>
      <authorList>
        <person name="Stopak K."/>
        <person name="de Noronha C."/>
        <person name="Yonemoto W."/>
        <person name="Greene W.C."/>
      </authorList>
      <dbReference type="PubMed" id="14527406"/>
      <dbReference type="DOI" id="10.1016/s1097-2765(03)00353-8"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 PROTEIN VIF (MICROBIAL INFECTION)</scope>
    <scope>PROTEASOME MEDIATED DEGRADATION</scope>
    <scope>TRANSLATION INHIBITION</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2003" name="Nat. Med." volume="9" first="1398" last="1403">
      <title>HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.</title>
      <authorList>
        <person name="Marin M."/>
        <person name="Rose K.M."/>
        <person name="Kozak S.L."/>
        <person name="Kabat D."/>
      </authorList>
      <dbReference type="PubMed" id="14528301"/>
      <dbReference type="DOI" id="10.1038/nm946"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 PROTEIN VIF (MICROBIAL INFECTION)</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2003" name="Nat. Med." volume="9" first="1404" last="1407">
      <title>The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.</title>
      <authorList>
        <person name="Sheehy A.M."/>
        <person name="Gaddis N.C."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="14528300"/>
      <dbReference type="DOI" id="10.1038/nm945"/>
    </citation>
    <scope>FUNCTION IN DNA C TO U EDITING</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2003" name="Trends Genet." volume="19" first="207" last="216">
      <title>Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.</title>
      <authorList>
        <person name="Wedekind J.E."/>
        <person name="Dance G.S.C."/>
        <person name="Sowden M.P."/>
        <person name="Smith H.C."/>
      </authorList>
      <dbReference type="PubMed" id="12683974"/>
      <dbReference type="DOI" id="10.1016/s0168-9525(03)00054-4"/>
    </citation>
    <scope>REVIEW ON APOBEC FAMILY</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2003" name="Trends Mol. Med." volume="9" first="409" last="413">
      <title>Death and the retrovirus.</title>
      <authorList>
        <person name="Vartanian J.P."/>
        <person name="Sommer P."/>
        <person name="Wain-Hobson S."/>
      </authorList>
      <dbReference type="PubMed" id="14557052"/>
      <dbReference type="DOI" id="10.1016/j.molmed.2003.08.008"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2003" name="Mol. Ther." volume="8" first="525" last="527">
      <title>HIV-1 Vif: counteracting innate antiretroviral defenses.</title>
      <authorList>
        <person name="Cullen B.R."/>
      </authorList>
      <dbReference type="PubMed" id="14565218"/>
      <dbReference type="DOI" id="10.1016/j.ymthe.2003.08.010"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="5652" last="5657">
      <title>A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.</title>
      <authorList>
        <person name="Xu H."/>
        <person name="Svarovskaia E.S."/>
        <person name="Barr R."/>
        <person name="Zhang Y."/>
        <person name="Khan M.A."/>
        <person name="Strebel K."/>
        <person name="Pathak V.K."/>
      </authorList>
      <dbReference type="PubMed" id="15054139"/>
      <dbReference type="DOI" id="10.1073/pnas.0400830101"/>
    </citation>
    <scope>MUTAGENESIS OF ASP-128</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2004" name="Science" volume="303" first="1829" last="1829">
      <title>Inhibition of hepatitis B virus replication by APOBEC3G.</title>
      <authorList>
        <person name="Turelli P."/>
        <person name="Mangeat B."/>
        <person name="Jost S."/>
        <person name="Vianin S."/>
        <person name="Trono D."/>
      </authorList>
      <dbReference type="PubMed" id="15031497"/>
      <dbReference type="DOI" id="10.1126/science.1092066"/>
    </citation>
    <scope>FUNCTION IN HBV INHIBITION</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2006" name="Curr. Biol." volume="16" first="480" last="485">
      <title>APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.</title>
      <authorList>
        <person name="Chen H."/>
        <person name="Lilley C.E."/>
        <person name="Yu Q."/>
        <person name="Lee D.V."/>
        <person name="Chou J."/>
        <person name="Narvaiza I."/>
        <person name="Landau N.R."/>
        <person name="Weitzman M.D."/>
      </authorList>
      <dbReference type="PubMed" id="16527742"/>
      <dbReference type="DOI" id="10.1016/j.cub.2006.01.031"/>
    </citation>
    <scope>FUNCTION IN RETROTRANSPOSITION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="36624" last="36631">
      <title>Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.</title>
      <authorList>
        <person name="Hakata Y."/>
        <person name="Landau N.R."/>
      </authorList>
      <dbReference type="PubMed" id="17020885"/>
      <dbReference type="DOI" id="10.1074/jbc.m604980200"/>
    </citation>
    <scope>DOMAIN CMP/DCMP DEAMINASE</scope>
    <scope>SUBUNIT</scope>
    <scope>MUTAGENESIS OF GLU-67 AND GLU-259</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2006" name="J. Exp. Med." volume="203" first="41" last="46">
      <title>Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.</title>
      <authorList>
        <person name="Peng G."/>
        <person name="Lei K.J."/>
        <person name="Jin W."/>
        <person name="Greenwell-Wild T."/>
        <person name="Wahl S.M."/>
      </authorList>
      <dbReference type="PubMed" id="16418394"/>
      <dbReference type="DOI" id="10.1084/jem.20051512"/>
    </citation>
    <scope>INDUCTION</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2006" name="J. Virol." volume="80" first="605" last="614">
      <title>Restriction of foamy viruses by APOBEC cytidine deaminases.</title>
      <authorList>
        <person name="Delebecque F."/>
        <person name="Suspene R."/>
        <person name="Calattini S."/>
        <person name="Casartelli N."/>
        <person name="Saib A."/>
        <person name="Froment A."/>
        <person name="Wain-Hobson S."/>
        <person name="Gessain A."/>
        <person name="Vartanian J.P."/>
        <person name="Schwartz O."/>
      </authorList>
      <dbReference type="PubMed" id="16378963"/>
      <dbReference type="DOI" id="10.1128/jvi.80.2.605-614.2006"/>
    </citation>
    <scope>FUNCTION IN SFV RESTRICTION</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2006" name="PLoS Pathog." volume="2" first="E41" last="E41">
      <title>Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies.</title>
      <authorList>
        <person name="Wichroski M.J."/>
        <person name="Robb G.B."/>
        <person name="Rana T.M."/>
      </authorList>
      <dbReference type="PubMed" id="16699599"/>
      <dbReference type="DOI" id="10.1371/journal.ppat.0020041"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH APOBEC3F; AGO2; EIF4E; EIF4ENIF1; DCP2 AND DDX6</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="2587" last="2595">
      <title>APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.</title>
      <authorList>
        <person name="Holmes R.K."/>
        <person name="Koning F.A."/>
        <person name="Bishop K.N."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="17121840"/>
      <dbReference type="DOI" id="10.1074/jbc.m607298200"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2008" name="Annu. Rev. Immunol." volume="26" first="317" last="353">
      <title>The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.</title>
      <authorList>
        <person name="Chiu Y.L."/>
        <person name="Greene W.C."/>
      </authorList>
      <dbReference type="PubMed" id="18304004"/>
      <dbReference type="DOI" id="10.1146/annurev.immunol.26.021607.090350"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2008" name="Curr. Opin. Infect. Dis." volume="21" first="298" last="303">
      <title>Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.</title>
      <authorList>
        <person name="Bonvin M."/>
        <person name="Greeve J."/>
      </authorList>
      <dbReference type="PubMed" id="18448976"/>
      <dbReference type="DOI" id="10.1097/qco.0b013e3282fe1bb2"/>
    </citation>
    <scope>REVIEW ON FUNCTION IN HBV RESTRICTION</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="33329" last="33336">
      <title>APOBEC3G subunits self-associate via the C-terminal deaminase domain.</title>
      <authorList>
        <person name="Bennett R.P."/>
        <person name="Salter J.D."/>
        <person name="Liu X."/>
        <person name="Wedekind J.E."/>
        <person name="Smith H.C."/>
      </authorList>
      <dbReference type="PubMed" id="18842592"/>
      <dbReference type="DOI" id="10.1074/jbc.m803726200"/>
    </citation>
    <scope>SUBUNIT</scope>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2008" name="J. Virol." volume="82" first="9591" last="9599">
      <title>Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.</title>
      <authorList>
        <person name="Stenglein M.D."/>
        <person name="Matsuo H."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="18667511"/>
      <dbReference type="DOI" id="10.1128/jvi.02471-07"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2008" name="Nat. Struct. Mol. Biol." volume="15" first="1184" last="1191">
      <title>Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.</title>
      <authorList>
        <person name="Shirakawa K."/>
        <person name="Takaori-Kondo A."/>
        <person name="Yokoyama M."/>
        <person name="Izumi T."/>
        <person name="Matsui M."/>
        <person name="Io K."/>
        <person name="Sato T."/>
        <person name="Sato H."/>
        <person name="Uchiyama T."/>
      </authorList>
      <dbReference type="PubMed" id="18836454"/>
      <dbReference type="DOI" id="10.1038/nsmb.1497"/>
    </citation>
    <scope>PHOSPHORYLATION AT THR-32</scope>
    <scope>INTERACTION WITH PRKACA</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2009" name="J. Virol." volume="83" first="7547" last="7559">
      <title>Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.</title>
      <authorList>
        <person name="Zielonka J."/>
        <person name="Bravo I.G."/>
        <person name="Marino D."/>
        <person name="Conrad E."/>
        <person name="Perkovic M."/>
        <person name="Battenberg M."/>
        <person name="Cichutek K."/>
        <person name="Muenk C."/>
      </authorList>
      <dbReference type="PubMed" id="19458006"/>
      <dbReference type="DOI" id="10.1128/jvi.00015-09"/>
    </citation>
    <scope>FUNCTION IN EIAV RESTRICTION</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2009" name="Philos. Trans. R. Soc. Lond., B, Biol. Sci." volume="364" first="689" last="703">
      <title>APOBEC3G: an intracellular centurion.</title>
      <authorList>
        <person name="Chiu Y.L."/>
        <person name="Greene W.C."/>
      </authorList>
      <dbReference type="PubMed" id="19008196"/>
      <dbReference type="DOI" id="10.1098/rstb.2008.0193"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="19539" last="19544">
      <title>HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain.</title>
      <authorList>
        <person name="Iwatani Y."/>
        <person name="Chan D.S."/>
        <person name="Liu L."/>
        <person name="Yoshii H."/>
        <person name="Shibata J."/>
        <person name="Yamamoto N."/>
        <person name="Levin J.G."/>
        <person name="Gronenborn A.M."/>
        <person name="Sugiura W."/>
      </authorList>
      <dbReference type="PubMed" id="19887642"/>
      <dbReference type="DOI" id="10.1073/pnas.0906652106"/>
    </citation>
    <scope>UBIQUITINATION AT LYS- 297; LYS-301; LYS-303 AND LYS-334 (MICROBIAL INFECTION)</scope>
    <scope>MUTAGENESIS OF 297-LYS--LYS-303 AND LYS-334</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2010" name="J. Virol." volume="84" first="5250" last="5259">
      <title>APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.</title>
      <authorList>
        <person name="Mbisa J.L."/>
        <person name="Bu W."/>
        <person name="Pathak V.K."/>
      </authorList>
      <dbReference type="PubMed" id="20219927"/>
      <dbReference type="DOI" id="10.1128/jvi.02358-09"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2010" name="J. Virol." volume="84" first="5719" last="5729">
      <title>Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.</title>
      <authorList>
        <person name="Paprotka T."/>
        <person name="Venkatachari N.J."/>
        <person name="Chaipan C."/>
        <person name="Burdick R."/>
        <person name="Delviks-Frankenberry K.A."/>
        <person name="Hu W.S."/>
        <person name="Pathak V.K."/>
      </authorList>
      <dbReference type="PubMed" id="20335265"/>
      <dbReference type="DOI" id="10.1128/jvi.00134-10"/>
    </citation>
    <scope>FUNCTION IN XMRV RESTRICTION</scope>
  </reference>
  <reference key="40">
    <citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="4274" last="4284">
      <title>Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.</title>
      <authorList>
        <person name="Refsland E.W."/>
        <person name="Stenglein M.D."/>
        <person name="Shindo K."/>
        <person name="Albin J.S."/>
        <person name="Brown W.L."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="20308164"/>
      <dbReference type="DOI" id="10.1093/nar/gkq174"/>
    </citation>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="41">
    <citation type="journal article" date="2010" name="Virus Res." volume="151" first="213" last="219">
      <title>APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems.</title>
      <authorList>
        <person name="Zhao D."/>
        <person name="Wang X."/>
        <person name="Lou G."/>
        <person name="Peng G."/>
        <person name="Li J."/>
        <person name="Zhu H."/>
        <person name="Chen F."/>
        <person name="Li S."/>
        <person name="Liu D."/>
        <person name="Chen Z."/>
        <person name="Yang Z."/>
      </authorList>
      <dbReference type="PubMed" id="20510315"/>
      <dbReference type="DOI" id="10.1016/j.virusres.2010.05.009"/>
    </citation>
    <scope>INTERACTION WITH HEPATITIS B VIRUS CAPSID PROTEIN (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="42">
    <citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="26568" last="26575">
      <title>Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein.</title>
      <authorList>
        <person name="Demorest Z.L."/>
        <person name="Li M."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="21659520"/>
      <dbReference type="DOI" id="10.1074/jbc.m111.235721"/>
    </citation>
    <scope>PHOSPHORYLATION AT THR-32 AND THR-218</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF THR-218</scope>
  </reference>
  <reference key="43">
    <citation type="journal article" date="2011" name="Nature" volume="481" first="371" last="375">
      <title>Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection.</title>
      <authorList>
        <person name="Jaeger S."/>
        <person name="Kim D.Y."/>
        <person name="Hultquist J.F."/>
        <person name="Shindo K."/>
        <person name="LaRue R.S."/>
        <person name="Kwon E."/>
        <person name="Li M."/>
        <person name="Anderson B.D."/>
        <person name="Yen L."/>
        <person name="Stanley D."/>
        <person name="Mahon C."/>
        <person name="Kane J."/>
        <person name="Franks-Skiba K."/>
        <person name="Cimermancic P."/>
        <person name="Burlingame A."/>
        <person name="Sali A."/>
        <person name="Craik C.S."/>
        <person name="Harris R.S."/>
        <person name="Gross J.D."/>
        <person name="Krogan N.J."/>
      </authorList>
      <dbReference type="PubMed" id="22190037"/>
      <dbReference type="DOI" id="10.1038/nature10693"/>
    </citation>
    <scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="44">
    <citation type="journal article" date="2011" name="J. Virol." volume="85" first="1765" last="1776">
      <title>Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.</title>
      <authorList>
        <person name="Bulliard Y."/>
        <person name="Narvaiza I."/>
        <person name="Bertero A."/>
        <person name="Peddi S."/>
        <person name="Roehrig U.F."/>
        <person name="Ortiz M."/>
        <person name="Zoete V."/>
        <person name="Castro-Diaz N."/>
        <person name="Turelli P."/>
        <person name="Telenti A."/>
        <person name="Michielin O."/>
        <person name="Weitzman M.D."/>
        <person name="Trono D."/>
      </authorList>
      <dbReference type="PubMed" id="21123384"/>
      <dbReference type="DOI" id="10.1128/jvi.01651-10"/>
    </citation>
    <scope>FUNCTION IN HOST DEFENSE</scope>
    <scope>MUTAGENESIS OF GLU-217 AND PRO-247</scope>
  </reference>
  <reference key="45">
    <citation type="journal article" date="2011" name="J. Virol." volume="85" first="11220" last="11234">
      <title>Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.</title>
      <authorList>
        <person name="Hultquist J.F."/>
        <person name="Lengyel J.A."/>
        <person name="Refsland E.W."/>
        <person name="LaRue R.S."/>
        <person name="Lackey L."/>
        <person name="Brown W.L."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="21835787"/>
      <dbReference type="DOI" id="10.1128/jvi.05238-11"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="46">
    <citation type="journal article" date="2011" name="Trends Biochem. Sci." volume="36" first="239" last="244">
      <title>APOBEC3G: a double agent in defense.</title>
      <authorList>
        <person name="Smith H.C."/>
      </authorList>
      <dbReference type="PubMed" id="21239176"/>
      <dbReference type="DOI" id="10.1016/j.tibs.2010.12.003"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="47">
    <citation type="journal article" date="2011" name="Virology" volume="414" first="130" last="136">
      <title>Functional analysis of the two cytidine deaminase domains in APOBEC3G.</title>
      <authorList>
        <person name="Li X."/>
        <person name="Ma J."/>
        <person name="Zhang Q."/>
        <person name="Zhou J."/>
        <person name="Yin X."/>
        <person name="Zhai C."/>
        <person name="You X."/>
        <person name="Yu L."/>
        <person name="Guo F."/>
        <person name="Zhao L."/>
        <person name="Li Z."/>
        <person name="Zeng Y."/>
        <person name="Cen S."/>
      </authorList>
      <dbReference type="PubMed" id="21489586"/>
      <dbReference type="DOI" id="10.1016/j.virol.2011.03.014"/>
    </citation>
    <scope>DOMAIN CMP/DCMP DEAMINASE</scope>
  </reference>
  <reference key="48">
    <citation type="journal article" date="2012" name="Front. Microbiol." volume="3" first="250" last="250">
      <title>Antiviral mechanism and biochemical basis of the human APOBEC3 family.</title>
      <authorList>
        <person name="Imahashi M."/>
        <person name="Nakashima M."/>
        <person name="Iwatani Y."/>
      </authorList>
      <dbReference type="PubMed" id="22787460"/>
      <dbReference type="DOI" id="10.3389/fmicb.2012.00250"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="49">
    <citation type="journal article" date="2012" name="Front. Microbiol." volume="3" first="275" last="275">
      <title>Retroelements versus APOBEC3 family members: No great escape from the magnificent seven.</title>
      <authorList>
        <person name="Arias J.F."/>
        <person name="Koyama T."/>
        <person name="Kinomoto M."/>
        <person name="Tokunaga K."/>
      </authorList>
      <dbReference type="PubMed" id="22912627"/>
      <dbReference type="DOI" id="10.3389/fmicb.2012.00275"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="50">
    <citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="29373" last="29383">
      <title>APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10.</title>
      <authorList>
        <person name="Liu C."/>
        <person name="Zhang X."/>
        <person name="Huang F."/>
        <person name="Yang B."/>
        <person name="Li J."/>
        <person name="Liu B."/>
        <person name="Luo H."/>
        <person name="Zhang P."/>
        <person name="Zhang H."/>
      </authorList>
      <dbReference type="PubMed" id="22791714"/>
      <dbReference type="DOI" id="10.1074/jbc.m112.354001"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH MOV10</scope>
  </reference>
  <reference key="51">
    <citation type="journal article" date="2012" name="J. Virol." volume="86" first="3777" last="3786">
      <title>The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.</title>
      <authorList>
        <person name="Wang X."/>
        <person name="Ao Z."/>
        <person name="Chen L."/>
        <person name="Kobinger G."/>
        <person name="Peng J."/>
        <person name="Yao X."/>
      </authorList>
      <dbReference type="PubMed" id="22301159"/>
      <dbReference type="DOI" id="10.1128/jvi.06594-11"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="52">
    <citation type="journal article" date="2012" name="J. Virol." volume="86" first="11712" last="11724">
      <title>HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies.</title>
      <authorList>
        <person name="Phalora P.K."/>
        <person name="Sherer N.M."/>
        <person name="Wolinsky S.M."/>
        <person name="Swanson C.M."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="22915799"/>
      <dbReference type="DOI" id="10.1128/jvi.00595-12"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH AGO1; AGO2 AND AGO3</scope>
  </reference>
  <reference key="53">
    <citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="1005" last="1010">
      <title>The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.</title>
      <authorList>
        <person name="Kitamura S."/>
        <person name="Ode H."/>
        <person name="Nakashima M."/>
        <person name="Imahashi M."/>
        <person name="Naganawa Y."/>
        <person name="Kurosawa T."/>
        <person name="Yokomaku Y."/>
        <person name="Yamane T."/>
        <person name="Watanabe N."/>
        <person name="Suzuki A."/>
        <person name="Sugiura W."/>
        <person name="Iwatani Y."/>
      </authorList>
      <dbReference type="PubMed" id="23001005"/>
      <dbReference type="DOI" id="10.1038/nsmb.2378"/>
    </citation>
    <scope>INTERACTION WITH HIV-1 VIF</scope>
    <scope>MUTAGENESIS OF PHE-74; LEU-80; TYR-86; PHE-107 AND ASP-128</scope>
  </reference>
  <reference key="54">
    <citation type="journal article" date="2012" name="PLoS Pathog." volume="8" first="E1002800" last="E1002800">
      <title>Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.</title>
      <authorList>
        <person name="Refsland E.W."/>
        <person name="Hultquist J.F."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="22807680"/>
      <dbReference type="DOI" id="10.1371/journal.ppat.1002800"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="55">
    <citation type="journal article" date="2012" name="PLoS Pathog." volume="8" first="e1003085" last="e1003085">
      <title>Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G.</title>
      <authorList>
        <person name="Stanley D.J."/>
        <person name="Bartholomeeusen K."/>
        <person name="Crosby D.C."/>
        <person name="Kim D.Y."/>
        <person name="Kwon E."/>
        <person name="Yen L."/>
        <person name="Cartozo N.C."/>
        <person name="Li M."/>
        <person name="Jaeger S."/>
        <person name="Mason-Herr J."/>
        <person name="Hayashi F."/>
        <person name="Yokoyama S."/>
        <person name="Krogan N.J."/>
        <person name="Harris R.S."/>
        <person name="Peterlin B.M."/>
        <person name="Gross J.D."/>
      </authorList>
      <dbReference type="PubMed" id="23300442"/>
      <dbReference type="DOI" id="10.1371/journal.ppat.1003085"/>
    </citation>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="56">
    <citation type="journal article" date="2012" name="Retrovirology" volume="9" first="35" last="35">
      <title>Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment.</title>
      <authorList>
        <person name="Monajemi M."/>
        <person name="Woodworth C.F."/>
        <person name="Benkaroun J."/>
        <person name="Grant M."/>
        <person name="Larijani M."/>
      </authorList>
      <dbReference type="PubMed" id="22546055"/>
      <dbReference type="DOI" id="10.1186/1742-4690-9-35"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="57">
    <citation type="journal article" date="2012" name="Semin. Cell Dev. Biol." volume="23" first="258" last="268">
      <title>Functions and regulation of the APOBEC family of proteins.</title>
      <authorList>
        <person name="Smith H.C."/>
        <person name="Bennett R.P."/>
        <person name="Kizilyer A."/>
        <person name="McDougall W.M."/>
        <person name="Prohaska K.M."/>
      </authorList>
      <dbReference type="PubMed" id="22001110"/>
      <dbReference type="DOI" id="10.1016/j.semcdb.2011.10.004"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="58">
    <citation type="journal article" date="2013" name="J. Virol." volume="87" first="444" last="453">
      <title>APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ t cells and macrophages.</title>
      <authorList>
        <person name="Chaipan C."/>
        <person name="Smith J.L."/>
        <person name="Hu W.S."/>
        <person name="Pathak V.K."/>
      </authorList>
      <dbReference type="PubMed" id="23097438"/>
      <dbReference type="DOI" id="10.1128/jvi.00676-12"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="59">
    <citation type="journal article" date="2013" name="J. Mol. Biol." volume="425" first="1172" last="1182">
      <title>Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.</title>
      <authorList>
        <person name="Albin J.S."/>
        <person name="Anderson J.S."/>
        <person name="Johnson J.R."/>
        <person name="Harjes E."/>
        <person name="Matsuo H."/>
        <person name="Krogan N.J."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="23318957"/>
      <dbReference type="DOI" id="10.1016/j.jmb.2013.01.010"/>
    </citation>
    <scope>UBIQUITINATION AT LYS-42; LYS-52; LYS-63; LYS-150; LYS-163; LYS-249; LYS-270; LYS-297; LYS-303 AND LYS-334 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="60">
    <citation type="journal article" date="2013" name="J. Virol." volume="87" first="1508" last="1517">
      <title>The suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4+ T cells is associated with the inhibition of processive reverse transcription as well as excessive cytidine deamination.</title>
      <authorList>
        <person name="Gillick K."/>
        <person name="Pollpeter D."/>
        <person name="Phalora P."/>
        <person name="Kim E.Y."/>
        <person name="Wolinsky S.M."/>
        <person name="Malim M.H."/>
      </authorList>
      <dbReference type="PubMed" id="23152537"/>
      <dbReference type="DOI" id="10.1128/jvi.02587-12"/>
    </citation>
    <scope>FUNCTION IN HIV-1 RESTRICTION</scope>
  </reference>
  <reference key="61">
    <citation type="journal article" date="2019" name="Cell Host Microbe" volume="26" first="86" last="99">
      <title>ARIH2 is a Vif-dependent regulator of CUL5-mediated APOBEC3G degradation in HIV infection.</title>
      <authorList>
        <person name="Huettenhain R."/>
        <person name="Xu J."/>
        <person name="Burton L.A."/>
        <person name="Gordon D.E."/>
        <person name="Hultquist J.F."/>
        <person name="Johnson J.R."/>
        <person name="Satkamp L."/>
        <person name="Hiatt J."/>
        <person name="Rhee D.Y."/>
        <person name="Baek K."/>
        <person name="Crosby D.C."/>
        <person name="Frankel A.D."/>
        <person name="Marson A."/>
        <person name="Harper J.W."/>
        <person name="Alpi A.F."/>
        <person name="Schulman B.A."/>
        <person name="Gross J.D."/>
        <person name="Krogan N.J."/>
      </authorList>
      <dbReference type="PubMed" id="31253590"/>
      <dbReference type="DOI" id="10.1016/j.chom.2019.05.008"/>
    </citation>
    <scope>UBIQUITINATION AT LYS--63; LYS-249; LYS-297; LYS-303 AND LYS-334 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="62">
    <citation type="journal article" date="2019" name="Elife" volume="8">
      <title>USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication.</title>
      <authorList>
        <person name="Pan T."/>
        <person name="Song Z."/>
        <person name="Wu L."/>
        <person name="Liu G."/>
        <person name="Ma X."/>
        <person name="Peng Z."/>
        <person name="Zhou M."/>
        <person name="Liang L."/>
        <person name="Liu B."/>
        <person name="Liu J."/>
        <person name="Zhang J."/>
        <person name="Zhang X."/>
        <person name="Huang R."/>
        <person name="Zhao J."/>
        <person name="Li Y."/>
        <person name="Ling X."/>
        <person name="Luo Y."/>
        <person name="Tang X."/>
        <person name="Cai W."/>
        <person name="Deng K."/>
        <person name="Li L."/>
        <person name="Zhang H."/>
      </authorList>
      <dbReference type="PubMed" id="31397674"/>
      <dbReference type="DOI" id="10.7554/elife.48318"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>DEUBIQUITINATION BY USP49 (MICROBIAL INFECTION)</scope>
  </reference>
  <reference key="63">
    <citation type="journal article" date="2019" name="Nat. Struct. Mol. Biol." volume="26" first="1176" last="1183">
      <title>Structural basis of antagonism of human APOBEC3F by HIV-1 Vif.</title>
      <authorList>
        <person name="Hu Y."/>
        <person name="Desimmie B.A."/>
        <person name="Nguyen H.C."/>
        <person name="Ziegler S.J."/>
        <person name="Cheng T.C."/>
        <person name="Chen J."/>
        <person name="Wang J."/>
        <person name="Wang H."/>
        <person name="Zhang K."/>
        <person name="Pathak V.K."/>
        <person name="Xiong Y."/>
      </authorList>
      <dbReference type="PubMed" id="31792451"/>
      <dbReference type="DOI" id="10.1038/s41594-019-0343-6"/>
    </citation>
    <scope>INTERACTION WITH APOBEC3F</scope>
  </reference>
  <reference key="64">
    <citation type="journal article" date="2008" name="Nature" volume="452" first="116" last="119">
      <title>Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.</title>
      <authorList>
        <person name="Chen K.M."/>
        <person name="Harjes E."/>
        <person name="Gross P.J."/>
        <person name="Fahmy A."/>
        <person name="Lu Y."/>
        <person name="Shindo K."/>
        <person name="Harris R.S."/>
        <person name="Matsuo H."/>
      </authorList>
      <dbReference type="PubMed" id="18288108"/>
      <dbReference type="DOI" id="10.1038/nature06638"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 198-384 IN COMPLEX WITH ZINC</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>COFACTOR</scope>
    <scope>FUNCTION</scope>
    <scope>ACTIVE SITE</scope>
    <scope>MUTAGENESIS OF ARG-213; ARG-215; GLU-259; TRP-285; ARG-313 AND ARG-320</scope>
  </reference>
  <reference key="65">
    <citation type="journal article" date="2008" name="Nature" volume="456" first="121" last="124">
      <title>Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.</title>
      <authorList>
        <person name="Holden L.G."/>
        <person name="Prochnow C."/>
        <person name="Chang Y.P."/>
        <person name="Bransteitter R."/>
        <person name="Chelico L."/>
        <person name="Sen U."/>
        <person name="Stevens R.C."/>
        <person name="Goodman M.F."/>
        <person name="Chen X.S."/>
      </authorList>
      <dbReference type="PubMed" id="18849968"/>
      <dbReference type="DOI" id="10.1038/nature07357"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 197-380 IN COMPLEX WITH ZINC</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVE SITE</scope>
    <scope>COFACTOR</scope>
    <scope>MUTAGENESIS OF ARG-213; ARG-215; ASN-244; TRP-285 AND TYR-315</scope>
  </reference>
  <reference key="66">
    <citation type="journal article" date="2009" name="EMBO J." volume="28" first="440" last="451">
      <title>Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G.</title>
      <authorList>
        <person name="Furukawa A."/>
        <person name="Nagata T."/>
        <person name="Matsugami A."/>
        <person name="Habu Y."/>
        <person name="Sugiyama R."/>
        <person name="Hayashi F."/>
        <person name="Kobayashi N."/>
        <person name="Yokoyama S."/>
        <person name="Takaku H."/>
        <person name="Katahira M."/>
      </authorList>
      <dbReference type="PubMed" id="19153609"/>
      <dbReference type="DOI" id="10.1038/emboj.2008.290"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 193-384 IN COMPLEX WITH ZINC</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>ACTIVE SITE</scope>
    <scope>COFACTOR</scope>
  </reference>
  <reference key="67">
    <citation type="journal article" date="2012" name="ACS Chem. Biol." volume="7" first="506" last="517">
      <title>First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.</title>
      <authorList>
        <person name="Li M."/>
        <person name="Shandilya S.M."/>
        <person name="Carpenter M.A."/>
        <person name="Rathore A."/>
        <person name="Brown W.L."/>
        <person name="Perkins A.L."/>
        <person name="Harki D.A."/>
        <person name="Solberg J."/>
        <person name="Hook D.J."/>
        <person name="Pandey K.K."/>
        <person name="Parniak M.A."/>
        <person name="Johnson J.R."/>
        <person name="Krogan N.J."/>
        <person name="Somasundaran M."/>
        <person name="Ali A."/>
        <person name="Schiffer C.A."/>
        <person name="Harris R.S."/>
      </authorList>
      <dbReference type="PubMed" id="22181350"/>
      <dbReference type="DOI" id="10.1021/cb200440y"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.38 ANGSTROMS) OF 191-380</scope>
  </reference>
  <reference evidence="62 63" key="68">
    <citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="4010" last="4021">
      <title>Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.</title>
      <authorList>
        <person name="Lu X."/>
        <person name="Zhang T."/>
        <person name="Xu Z."/>
        <person name="Liu S."/>
        <person name="Zhao B."/>
        <person name="Lan W."/>
        <person name="Wang C."/>
        <person name="Ding J."/>
        <person name="Cao C."/>
      </authorList>
      <dbReference type="PubMed" id="25542899"/>
      <dbReference type="DOI" id="10.1074/jbc.m114.624262"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 193-384 IN COMPLEX WITH ZINC</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
    <scope>SUBUNIT</scope>
    <scope>ACTIVE SITE</scope>
    <scope>COFACTOR</scope>
    <scope>MUTAGENESIS OF PRO-210; GLN-245; HIS-248; HIS-250; ARG-256; ASP-264; PHE-268; ASP-370; ARG-374; ARG-376 AND GLN-380</scope>
  </reference>
  <reference evidence="64 65 66" key="69">
    <citation type="journal article" date="2023" name="Nature" volume="615" first="728" last="733">
      <title>The structural basis for HIV-1 Vif antagonism of human APOBEC3G.</title>
      <authorList>
        <person name="Li Y.L."/>
        <person name="Langley C.A."/>
        <person name="Azumaya C.M."/>
        <person name="Echeverria I."/>
        <person name="Chesarino N.M."/>
        <person name="Emerman M."/>
        <person name="Cheng Y."/>
        <person name="Gross J.D."/>
      </authorList>
      <dbReference type="PubMed" id="36754086"/>
      <dbReference type="DOI" id="10.1038/s41586-023-05779-1"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (2.70 ANGSTROMS) IN COMPLEX WITH ZINC; CBFB; CUL5; ELOB; ELOC AND HIV-1 VIF</scope>
    <scope>COFACTOR</scope>
    <scope>ACTIVE SITE</scope>
    <scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
  </reference>
  <reference evidence="67 68" key="70">
    <citation type="journal article" date="2023" name="Nat. Commun." volume="14" first="4037" last="4037">
      <title>Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G.</title>
      <authorList>
        <person name="Kouno T."/>
        <person name="Shibata S."/>
        <person name="Shigematsu M."/>
        <person name="Hyun J."/>
        <person name="Kim T.G."/>
        <person name="Matsuo H."/>
        <person name="Wolf M."/>
      </authorList>
      <dbReference type="PubMed" id="37419875"/>
      <dbReference type="DOI" id="10.1038/s41467-023-39796-5"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (2.50 ANGSTROMS) OF 11-384 IN COMPLEX WITH ZINC; CBFB AND HIV-1 VIF</scope>
    <scope>COFACTOR</scope>
    <scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
    <scope>UBIQUITINATION (MICROBIAL INFECTION)</scope>
    <scope>INTERACTION WITH HIV-1 VIF (MICROBIAL INFECTION)</scope>
    <scope>MUTAGENESIS OF ASP-128; 297-LYS--LYS-303 AND LYS-334</scope>
  </reference>
  <comment type="function">
    <text evidence="3 4 5 6 7 8 10 12 13 15 17 20 21 25 26 27 29 31 33 36 39 40 41 43 44 46 48 55">DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms (PubMed:12808465, PubMed:16527742, PubMed:17121840, PubMed:18288108, PubMed:18849968, PubMed:19153609, PubMed:21123384, PubMed:22791714, PubMed:25542899). Exhibits potent antiviral activity against Vif-deficient HIV-1 (PubMed:12167863, PubMed:12859895, PubMed:14557625, PubMed:20219927, PubMed:21835787, PubMed:22807680, PubMed:22915799, PubMed:23097438, PubMed:23152537, PubMed:31397674). After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA (PubMed:12808465, PubMed:12808466, PubMed:12809610, PubMed:12970355, PubMed:14528300, PubMed:22807680). The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells (PubMed:12808465, PubMed:12808466, PubMed:12809610, PubMed:12970355, PubMed:14528300). Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA (PubMed:12808465, PubMed:12809610, PubMed:12970355, PubMed:14528300). Exhibits antiviral activity also against simian immunodeficiency viruses (SIVs), hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV) (PubMed:15031497, PubMed:16378963, PubMed:18448976, PubMed:19458006, PubMed:20335265). May inhibit the mobility of LTR and non-LTR retrotransposons (PubMed:16527742).</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="4 21 25 26 46">
      <text>a 2'-deoxycytidine in single-stranded DNA + H(+) + H2O = a 2'-deoxyuridine in single-stranded DNA + NH4(+)</text>
      <dbReference type="Rhea" id="RHEA:50948"/>
      <dbReference type="Rhea" id="RHEA-COMP:12846"/>
      <dbReference type="Rhea" id="RHEA-COMP:12847"/>
      <dbReference type="ChEBI" id="CHEBI:15377"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:28938"/>
      <dbReference type="ChEBI" id="CHEBI:85452"/>
      <dbReference type="ChEBI" id="CHEBI:133902"/>
      <dbReference type="EC" id="3.5.4.38"/>
    </reaction>
  </comment>
  <comment type="cofactor">
    <cofactor evidence="4 21 25 26 46 50 51">
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </cofactor>
  </comment>
  <comment type="activity regulation">
    <text evidence="36 37 50 51">(Microbial infection) Antiviral activity is neutralized by the HIV-1 virion infectivity factor (Vif), that prevents its incorporation into progeny virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome (PubMed:21835787, PubMed:22190037, PubMed:36754086, PubMed:37419875). Can also be neutralized by simian immunodeficiency virus sooty mangabey monkey virus (SIV-sm) and chimpanzee immunodeficiency virus (SIV-cpz) Vif (PubMed:21835787).</text>
  </comment>
  <comment type="biophysicochemical properties">
    <kinetics>
      <KM evidence="46">20.42 uM for 2'-deoxycytidine in single-stranded DNA</KM>
      <text evidence="46">kcat is 0.11 min(-1) with 2'-deoxycytidine in single-stranded DNA as substrate.</text>
    </kinetics>
  </comment>
  <comment type="subunit">
    <text evidence="2 18 19 23 24 39 41 46 49">Homodimer (PubMed:11863358, PubMed:17020885, PubMed:18842592, PubMed:25542899). Homooligomer (PubMed:11863358, PubMed:17020885, PubMed:18842592). Can bind RNA to form ribonucleoprotein complexes of high-molecular-mass (HMM) or low-molecular-mass (LMM) (PubMed:11863358, PubMed:17020885, PubMed:18842592). HMM is inactive and heterogeneous in protein composition because of binding nonselectively to cellular RNAs, which in turn are associated with variety of cellular proteins (PubMed:11863358, PubMed:17020885, PubMed:18842592). The LMM form which is enzymatically active has few or no RNAs associated (PubMed:11863358, PubMed:17020885, PubMed:18842592). Its ability to form homooligomer is distinct from its ability to assemble into HMM (PubMed:11863358, PubMed:17020885, PubMed:18842592). Interacts with APOBEC3B, APOBEC3F, MOV10, AGO2, EIF4E, EIF4ENIF1, DCP2 and DDX6 in an RNA-dependent manner (PubMed:16699599, PubMed:22791714, PubMed:31792451). Interacts with AGO1, AGO3 and PKA/PRKACA (PubMed:18836454, PubMed:22915799).</text>
  </comment>
  <comment type="subunit">
    <text evidence="7 9 11 37 42 50 51">(Microbial infection) Interacts with HIV-1 Vif; promoting its ubiquitination by a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex) hijacked by the HIV-1 Vif.</text>
  </comment>
  <comment type="subunit">
    <text evidence="38">(Microbial infection) Interacts with HIV-1 reverse transcriptase/ribonuclease H.</text>
  </comment>
  <comment type="subunit">
    <text evidence="32">(Microbial infection) Interacts with hepatitis B virus capsid protein.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-717839">
      <id>Q9HC16</id>
    </interactant>
    <interactant intactId="EBI-717839">
      <id>Q9HC16</id>
      <label>APOBEC3G</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-717839">
      <id>Q9HC16</id>
    </interactant>
    <interactant intactId="EBI-476586">
      <id>P17612</id>
      <label>PRKACA</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>6</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-717839">
      <id>Q9HC16</id>
    </interactant>
    <interactant intactId="EBI-15528966">
      <id>P69723</id>
      <label>vif</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-717839">
      <id>Q9HC16</id>
    </interactant>
    <interactant intactId="EBI-15731903">
      <id>Q77YG0</id>
      <label>vif</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="5 17 18 22 35 36">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="22">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="18 41">Cytoplasm</location>
      <location evidence="18 41">P-body</location>
    </subcellularLocation>
    <text evidence="7 17 18 22 36">Mainly cytoplasmic (PubMed:16527742, PubMed:16699599, PubMed:21835787). Small amount are found in the nucleus (PubMed:18667511). During HIV-1 infection, virion-encapsidated in absence of HIV-1 Vif (PubMed:12859895).</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>Q9HC16-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>Q9HC16-3</id>
      <name>3</name>
      <sequence type="described" ref="VSP_009588 VSP_009589"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="2 3 30">Expressed in spleen, testes, ovary and peripheral blood leukocytes and CD4+ lymphocytes. Also expressed in non-permissive peripheral blood mononuclear cells, and several tumor cell lines; no expression detected in permissive lymphoid and non-lymphoid cell lines. Exists only in the LMM form in peripheral blood-derived resting CD4 T-cells and monocytes, both of which are refractory to HIV-1 infection. LMM is converted to a HMM complex when resting CD4 T-cells are activated or when monocytes are induced to differentiate into macrophages. This change correlates with increased susceptibility of these cells to HIV-1 infection.</text>
  </comment>
  <comment type="induction">
    <text evidence="16">Up-regulated by IFN-alpha.</text>
  </comment>
  <comment type="domain">
    <text evidence="19 34">The CMP/dCMP deaminase domain 1 mediates RNA binding, RNA-dependent oligomerization and virion incorporation whereas the CMP/dCMP deaminase domain 2 confers deoxycytidine deaminase activity and substrate sequence specificity.</text>
  </comment>
  <comment type="PTM">
    <text evidence="10 11 28 37 45 47 48 50 51">(Microbial infection) Following infection by HIV-1, ubiquitinated by a cullin-5-RING E3 ubiquitin-protein ligase complex (ECS complex) hijacked by the HIV-1 Vif protein, leading to its degradation (PubMed:14528300, PubMed:14528301, PubMed:19887642, PubMed:22190037, PubMed:23300442, PubMed:31253590, PubMed:36754086, PubMed:37419875). Deubiquitinated by USP49; leading to stabilization (PubMed:31397674).</text>
  </comment>
  <comment type="PTM">
    <text evidence="23 35">Phosphorylation at Thr-32 reduces its binding to HIV-1 Vif and subsequent ubiquitination and degradation thus promoting its antiviral activity.</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="4 40">Accumulation of APOBEC3G induced non-lethal hypermutation could contribute to the genetic variation of primate lentiviral populations.</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="2">It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 3</molecule>
    <text evidence="57">May be due to a competing donor splice site.</text>
  </comment>
  <comment type="similarity">
    <text evidence="57">Belongs to the cytidine and deoxycytidylate deaminase family.</text>
  </comment>
  <comment type="online information" name="Protein Spotlight">
    <link uri="https://web.expasy.org/spotlight/back_issues/045"/>
    <text>Protein wars - Issue 45 of April 2004</text>
  </comment>
  <dbReference type="EC" id="3.5.4.38" evidence="4 21 25 26 46"/>
  <dbReference type="EMBL" id="AK022802">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK315650">
    <property type="protein sequence ID" value="BAG38016.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AF182420">
    <property type="protein sequence ID" value="AAG14956.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CR456472">
    <property type="protein sequence ID" value="CAG30358.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="DQ147772">
    <property type="protein sequence ID" value="AAZ38722.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL022318">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL078641">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471095">
    <property type="protein sequence ID" value="EAW60292.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC024268">
    <property type="protein sequence ID" value="AAH24268.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC061914">
    <property type="protein sequence ID" value="AAH61914.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS13984.1">
    <molecule id="Q9HC16-1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_068594.1">
    <molecule id="Q9HC16-1"/>
    <property type="nucleotide sequence ID" value="NM_021822.3"/>
  </dbReference>
  <dbReference type="PDB" id="2JYW">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=198-384"/>
  </dbReference>
  <dbReference type="PDB" id="2KBO">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=193-384"/>
  </dbReference>
  <dbReference type="PDB" id="2KEM">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=191-384"/>
  </dbReference>
  <dbReference type="PDB" id="3E1U">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A=197-380"/>
  </dbReference>
  <dbReference type="PDB" id="3IQS">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A=197-380"/>
  </dbReference>
  <dbReference type="PDB" id="3IR2">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.25 A"/>
    <property type="chains" value="A/B=191-384"/>
  </dbReference>
  <dbReference type="PDB" id="3V4J">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.04 A"/>
    <property type="chains" value="A/B=191-384"/>
  </dbReference>
  <dbReference type="PDB" id="3V4K">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.38 A"/>
    <property type="chains" value="A/B=191-380"/>
  </dbReference>
  <dbReference type="PDB" id="4ROV">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.80 A"/>
    <property type="chains" value="A/B=193-384"/>
  </dbReference>
  <dbReference type="PDB" id="4ROW">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.70 A"/>
    <property type="chains" value="A=193-384"/>
  </dbReference>
  <dbReference type="PDB" id="5ZVA">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.30 A"/>
    <property type="chains" value="A/B=198-221"/>
  </dbReference>
  <dbReference type="PDB" id="5ZVB">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A/B=198-221"/>
  </dbReference>
  <dbReference type="PDB" id="6BUX">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.86 A"/>
    <property type="chains" value="A=189-384"/>
  </dbReference>
  <dbReference type="PDB" id="6BWY">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="A/B/E/G=195-384"/>
  </dbReference>
  <dbReference type="PDB" id="6K3J">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=197-384"/>
  </dbReference>
  <dbReference type="PDB" id="6K3K">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=197-384"/>
  </dbReference>
  <dbReference type="PDB" id="7UXD">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.50 A"/>
    <property type="chains" value="A=191-384"/>
  </dbReference>
  <dbReference type="PDB" id="8CX0">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="A=1-384"/>
  </dbReference>
  <dbReference type="PDB" id="8CX1">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.30 A"/>
    <property type="chains" value="A/F=1-384"/>
  </dbReference>
  <dbReference type="PDB" id="8CX2">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.20 A"/>
    <property type="chains" value="A/F=1-384"/>
  </dbReference>
  <dbReference type="PDB" id="8H0I">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A/B=11-384"/>
  </dbReference>
  <dbReference type="PDB" id="8J62">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A/B=11-384"/>
  </dbReference>
  <dbReference type="PDBsum" id="2JYW"/>
  <dbReference type="PDBsum" id="2KBO"/>
  <dbReference type="PDBsum" id="2KEM"/>
  <dbReference type="PDBsum" id="3E1U"/>
  <dbReference type="PDBsum" id="3IQS"/>
  <dbReference type="PDBsum" id="3IR2"/>
  <dbReference type="PDBsum" id="3V4J"/>
  <dbReference type="PDBsum" id="3V4K"/>
  <dbReference type="PDBsum" id="4ROV"/>
  <dbReference type="PDBsum" id="4ROW"/>
  <dbReference type="PDBsum" id="5ZVA"/>
  <dbReference type="PDBsum" id="5ZVB"/>
  <dbReference type="PDBsum" id="6BUX"/>
  <dbReference type="PDBsum" id="6BWY"/>
  <dbReference type="PDBsum" id="6K3J"/>
  <dbReference type="PDBsum" id="6K3K"/>
  <dbReference type="PDBsum" id="7UXD"/>
  <dbReference type="PDBsum" id="8CX0"/>
  <dbReference type="PDBsum" id="8CX1"/>
  <dbReference type="PDBsum" id="8CX2"/>
  <dbReference type="PDBsum" id="8H0I"/>
  <dbReference type="PDBsum" id="8J62"/>
  <dbReference type="AlphaFoldDB" id="Q9HC16"/>
  <dbReference type="EMDB" id="EMD-27032"/>
  <dbReference type="EMDB" id="EMD-27033"/>
  <dbReference type="EMDB" id="EMD-27034"/>
  <dbReference type="EMDB" id="EMD-34412"/>
  <dbReference type="EMDB" id="EMD-35999"/>
  <dbReference type="SASBDB" id="Q9HC16"/>
  <dbReference type="SMR" id="Q9HC16"/>
  <dbReference type="BioGRID" id="121920">
    <property type="interactions" value="29"/>
  </dbReference>
  <dbReference type="DIP" id="DIP-37519N"/>
  <dbReference type="IntAct" id="Q9HC16">
    <property type="interactions" value="11"/>
  </dbReference>
  <dbReference type="STRING" id="9606.ENSP00000385057"/>
  <dbReference type="BindingDB" id="Q9HC16"/>
  <dbReference type="ChEMBL" id="CHEMBL1741217"/>
  <dbReference type="iPTMnet" id="Q9HC16"/>
  <dbReference type="PhosphoSitePlus" id="Q9HC16"/>
  <dbReference type="SwissPalm" id="Q9HC16"/>
  <dbReference type="BioMuta" id="APOBEC3G"/>
  <dbReference type="DMDM" id="44887683"/>
  <dbReference type="jPOST" id="Q9HC16"/>
  <dbReference type="MassIVE" id="Q9HC16"/>
  <dbReference type="PaxDb" id="9606-ENSP00000385057"/>
  <dbReference type="PeptideAtlas" id="Q9HC16"/>
  <dbReference type="ProteomicsDB" id="81623">
    <molecule id="Q9HC16-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="81624">
    <molecule id="Q9HC16-3"/>
  </dbReference>
  <dbReference type="Pumba" id="Q9HC16"/>
  <dbReference type="Antibodypedia" id="34782">
    <property type="antibodies" value="671 antibodies from 40 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="60489"/>
  <dbReference type="Ensembl" id="ENST00000407997.4">
    <molecule id="Q9HC16-1"/>
    <property type="protein sequence ID" value="ENSP00000385057.3"/>
    <property type="gene ID" value="ENSG00000239713.9"/>
  </dbReference>
  <dbReference type="GeneID" id="60489"/>
  <dbReference type="KEGG" id="hsa:60489"/>
  <dbReference type="MANE-Select" id="ENST00000407997.4">
    <property type="protein sequence ID" value="ENSP00000385057.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_021822.4"/>
    <property type="RefSeq protein sequence ID" value="NP_068594.1"/>
  </dbReference>
  <dbReference type="UCSC" id="uc003awx.3">
    <molecule id="Q9HC16-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:17357"/>
  <dbReference type="CTD" id="60489"/>
  <dbReference type="DisGeNET" id="60489"/>
  <dbReference type="GeneCards" id="APOBEC3G"/>
  <dbReference type="HGNC" id="HGNC:17357">
    <property type="gene designation" value="APOBEC3G"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000239713">
    <property type="expression patterns" value="Tissue enhanced (lymphoid)"/>
  </dbReference>
  <dbReference type="MIM" id="607113">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q9HC16"/>
  <dbReference type="OpenTargets" id="ENSG00000239713"/>
  <dbReference type="PharmGKB" id="PA24897"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000239713"/>
  <dbReference type="eggNOG" id="KOG4075">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000161999"/>
  <dbReference type="HOGENOM" id="CLU_047918_0_0_1"/>
  <dbReference type="InParanoid" id="Q9HC16"/>
  <dbReference type="OMA" id="FLCNQAP"/>
  <dbReference type="OrthoDB" id="5355962at2759"/>
  <dbReference type="PhylomeDB" id="Q9HC16"/>
  <dbReference type="TreeFam" id="TF331356"/>
  <dbReference type="BRENDA" id="3.5.4.38">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="BRENDA" id="3.5.4.B9">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="Q9HC16"/>
  <dbReference type="Reactome" id="R-HSA-180585">
    <property type="pathway name" value="Vif-mediated degradation of APOBEC3G"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-180689">
    <property type="pathway name" value="APOBEC3G mediated resistance to HIV-1 infection"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q9HC16"/>
  <dbReference type="SIGNOR" id="Q9HC16"/>
  <dbReference type="BioGRID-ORCS" id="60489">
    <property type="hits" value="17 hits in 1171 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="APOBEC3G">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q9HC16"/>
  <dbReference type="GeneWiki" id="APOBEC3G"/>
  <dbReference type="GenomeRNAi" id="60489"/>
  <dbReference type="Pharos" id="Q9HC16">
    <property type="development level" value="Tchem"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q9HC16"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 22"/>
  </dbReference>
  <dbReference type="RNAct" id="Q9HC16">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000239713">
    <property type="expression patterns" value="Expressed in granulocyte and 188 other cell types or tissues"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030895">
    <property type="term" value="C:apolipoprotein B mRNA editing enzyme complex"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000932">
    <property type="term" value="C:P-body"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990904">
    <property type="term" value="C:ribonucleoprotein complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004126">
    <property type="term" value="F:cytidine deaminase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008829">
    <property type="term" value="F:dCTP deaminase activity"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042802">
    <property type="term" value="F:identical protein binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008270">
    <property type="term" value="F:zinc ion binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016553">
    <property type="term" value="P:base conversion or substitution editing"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009972">
    <property type="term" value="P:cytidine deamination"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016554">
    <property type="term" value="P:cytidine to uridine editing"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051607">
    <property type="term" value="P:defense response to virus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070383">
    <property type="term" value="P:DNA cytosine deamination"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045869">
    <property type="term" value="P:negative regulation of single stranded viral RNA replication via double stranded DNA intermediate"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045071">
    <property type="term" value="P:negative regulation of viral genome replication"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0048525">
    <property type="term" value="P:negative regulation of viral process"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002230">
    <property type="term" value="P:positive regulation of defense response to virus by host"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HGNC-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010526">
    <property type="term" value="P:retrotransposon silencing"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="CDD" id="cd01283">
    <property type="entry name" value="cytidine_deaminase"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.40.140.10">
    <property type="entry name" value="Cytidine Deaminase, domain 2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR016192">
    <property type="entry name" value="APOBEC/CMP_deaminase_Zn-bd"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR050610">
    <property type="entry name" value="APOBEC_Cyt_Deaminase"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002125">
    <property type="entry name" value="CMP_dCMP_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR016193">
    <property type="entry name" value="Cytidine_deaminase-like"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR13857:SF20">
    <property type="entry name" value="DNA DC-DU-EDITING ENZYME APOBEC-3G"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR13857">
    <property type="entry name" value="MRNA EDITING ENZYME"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF18782">
    <property type="entry name" value="NAD2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF53927">
    <property type="entry name" value="Cytidine deaminase-like"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00903">
    <property type="entry name" value="CYT_DCMP_DEAMINASES_1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51747">
    <property type="entry name" value="CYT_DCMP_DEAMINASES_2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0051">Antiviral defense</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0945">Host-virus interaction</keyword>
  <keyword id="KW-0378">Hydrolase</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0399">Innate immunity</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0479">Metal-binding</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <keyword id="KW-0862">Zinc</keyword>
  <feature type="chain" id="PRO_0000171761" description="DNA dC-&gt;dU-editing enzyme APOBEC-3G">
    <location>
      <begin position="1"/>
      <end position="384"/>
    </location>
  </feature>
  <feature type="domain" description="CMP/dCMP-type deaminase 1" evidence="1">
    <location>
      <begin position="29"/>
      <end position="138"/>
    </location>
  </feature>
  <feature type="domain" description="CMP/dCMP-type deaminase 2" evidence="1">
    <location>
      <begin position="214"/>
      <end position="328"/>
    </location>
  </feature>
  <feature type="region of interest" description="Essential for cytoplasmic localization">
    <location>
      <begin position="1"/>
      <end position="60"/>
    </location>
  </feature>
  <feature type="region of interest" description="Necessary for homooligomerization">
    <location>
      <begin position="209"/>
      <end position="336"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with DNA" evidence="57">
    <location>
      <begin position="213"/>
      <end position="215"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with DNA" evidence="57">
    <location>
      <begin position="313"/>
      <end position="320"/>
    </location>
  </feature>
  <feature type="active site" description="Proton donor" evidence="1 21 25 26 46 50 62 63 64 65">
    <location>
      <position position="259"/>
    </location>
  </feature>
  <feature type="binding site" evidence="1 50 51 64 65 67 68">
    <location>
      <position position="65"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 50 51 64 65 67 68">
    <location>
      <position position="97"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1 50 51 64 65 67 68">
    <location>
      <position position="100"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>1</label>
    </ligand>
  </feature>
  <feature type="binding site" evidence="21 25 26 46 50 51 62 63 64 65 67 68">
    <location>
      <position position="257"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="binding site" evidence="21 25 26 46 50 51 62 63 64 65 67 68">
    <location>
      <position position="288"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="binding site" evidence="21 25 26 46 50 51 62 63 64 65 67 68">
    <location>
      <position position="291"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
      <label>2</label>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="site" description="Interaction with DNA" evidence="57">
    <location>
      <position position="244"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by PKA" evidence="23 35">
    <location>
      <position position="32"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine; by PKA and CAMK2" evidence="35">
    <location>
      <position position="218"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
    <location>
      <position position="42"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
    <location>
      <position position="52"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59 60">
    <location>
      <position position="63"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
    <location>
      <position position="150"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
    <location>
      <position position="163"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59 60">
    <location>
      <position position="249"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="59">
    <location>
      <position position="270"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="58 59 60">
    <location>
      <position position="297"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="58">
    <location>
      <position position="301"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="58 59 60">
    <location>
      <position position="303"/>
    </location>
  </feature>
  <feature type="cross-link" description="(Microbial infection) Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="58 59 60">
    <location>
      <position position="334"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_009588" description="In isoform 3." evidence="54">
    <original>VYSELKYHPEMRFFHWFSKWRK</original>
    <variation>VPPGLQSLCRQELSQLGKQTTH</variation>
    <location>
      <begin position="58"/>
      <end position="79"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_009589" description="In isoform 3." evidence="54">
    <location>
      <begin position="80"/>
      <end position="384"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_017837" description="In dbSNP:rs8177832." evidence="52">
    <original>H</original>
    <variation>R</variation>
    <location>
      <position position="186"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_048723" description="In dbSNP:rs17000736.">
    <original>R</original>
    <variation>H</variation>
    <location>
      <position position="256"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_025060" description="In dbSNP:rs17496046." evidence="52">
    <original>Q</original>
    <variation>E</variation>
    <location>
      <position position="275"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of cytidine deaminase activity and significant decrease in antiviral activity; when associated with A-259." evidence="5 8 19">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on cytidine deaminase and antiviral activity." evidence="5 8 19">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity." evidence="5 8 19">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="67"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Remains sensitive to HIV-1 Vif and able to bind Vif." evidence="42">
    <original>F</original>
    <variation>W</variation>
    <location>
      <position position="74"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Remains sensitive to HIV-1 Vif and able to bind Vif." evidence="42">
    <original>L</original>
    <variation>D</variation>
    <location>
      <position position="80"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity." evidence="4 5">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="81"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not decrease cytidine deaminase activity." evidence="5">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="85"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Remains sensitive to HIV-1 Vif and able to bind Vif." evidence="42">
    <original>Y</original>
    <variation>A</variation>
    <location>
      <position position="86"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity." evidence="4 5">
    <original>C</original>
    <variation>A</variation>
    <location>
      <position position="97"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity." evidence="4 5 8">
    <original>C</original>
    <variation>A</variation>
    <variation>S</variation>
    <location>
      <position position="100"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Remains sensitive to HIV-1 Vif and able to bind Vif." evidence="42">
    <original>F</original>
    <variation>K</variation>
    <location>
      <position position="107"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Resistant to HIV-1 Vif with complete loss of Vif-induced ubiquitination and degradation and Vif binding." evidence="14 42 51">
    <original>D</original>
    <variation>K</variation>
    <location>
      <position position="128"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Nearly abolished catalytic efficiency of cytidine deaminase activity." evidence="46">
    <original>P</original>
    <variation>A</variation>
    <variation>G</variation>
    <location>
      <position position="210"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Slightly reduces enzyme activity." evidence="21 25">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="213"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduces enzyme activity." evidence="21 25">
    <original>R</original>
    <variation>E</variation>
    <location>
      <position position="213"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="21 25">
    <original>R</original>
    <variation>A</variation>
    <variation>E</variation>
    <location>
      <position position="215"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Modifies the spectrum of action against mobile genetic elements; when associated with K-247." evidence="33">
    <original>E</original>
    <variation>K</variation>
    <location>
      <position position="217"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of phosphorylation. No effect on cytidine deaminase activity or HIV-1 restriction activity." evidence="35">
    <original>T</original>
    <variation>A</variation>
    <location>
      <position position="218"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Phosphomimetic mutant which shows loss of cytidine deaminase activity and HIV-1 restriction activity." evidence="35">
    <original>T</original>
    <variation>E</variation>
    <location>
      <position position="218"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not decrease cytidine deaminase activity." evidence="5">
    <original>C</original>
    <variation>S</variation>
    <location>
      <position position="221"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="25">
    <original>N</original>
    <variation>A</variation>
    <location>
      <position position="244"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Nearly abolished cytidine deaminase activity." evidence="46">
    <original>Q</original>
    <variation>A</variation>
    <location>
      <position position="245"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Modifies the spectrum of action against mobile genetic elements; when associated with K-217." evidence="33">
    <original>P</original>
    <variation>K</variation>
    <location>
      <position position="247"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Improved catalytic efficiency of cytidine deaminase activity." evidence="46">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="248"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Improved catalytic efficiency of cytidine deaminase activity." evidence="46">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="250"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced cytidine deaminase activity." evidence="46">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="256"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity." evidence="4 5">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="257"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of cytidine deaminase activity and significant decrease in antiviral activity." evidence="5 8 19 21">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="259"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of cytidine deaminase activity and significant decrease in antiviral activity; when associated with A-67." evidence="5 8 19 21">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="259"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity and antiviral activity." evidence="5 8 19 21">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="259"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Nearly abolished cytidine deaminase activity." evidence="46">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="264"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced cytidine deaminase activity." evidence="46">
    <original>F</original>
    <variation>A</variation>
    <location>
      <position position="268"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="21 25">
    <original>W</original>
    <variation>A</variation>
    <location>
      <position position="285"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity." evidence="4 5">
    <original>C</original>
    <variation>A</variation>
    <location>
      <position position="288"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreases cytidine deaminase activity." evidence="4 5 8">
    <original>C</original>
    <variation>A</variation>
    <variation>S</variation>
    <location>
      <position position="291"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 4KR mutant; decreased ubiquitination and degradation by an ECS complex hijacked by HIV-1 Vif; when associated with R-334." evidence="28 51">
    <original>KFISKNK</original>
    <variation>RFISRNR</variation>
    <location>
      <begin position="297"/>
      <end position="303"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="21">
    <original>R</original>
    <variation>A</variation>
    <variation>E</variation>
    <location>
      <position position="313"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes enzyme activity." evidence="25">
    <original>Y</original>
    <variation>A</variation>
    <location>
      <position position="315"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Slightly reduces enzyme activity." evidence="21">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="320"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduces enzyme activity." evidence="21">
    <original>R</original>
    <variation>E</variation>
    <location>
      <position position="320"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Does not decrease cytidine deaminase activity." evidence="5">
    <original>E</original>
    <variation>Q</variation>
    <location>
      <position position="323"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="In 4KR mutant; decreased ubiquitination and degradation by an ECS complex hijacked by HIV-1 Vif; when associated with R-297--R-303." evidence="28">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="334"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced catalytic efficiency of cytidine deaminase activity." evidence="46">
    <original>D</original>
    <variation>A</variation>
    <location>
      <position position="370"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced cytidine deaminase activity." evidence="46">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="374"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced cytidine deaminase activity." evidence="46">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="376"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly reduced cytidine deaminase activity." evidence="46">
    <original>Q</original>
    <variation>A</variation>
    <location>
      <position position="380"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; no nucleotide entry." evidence="57" ref="1">
    <original>S</original>
    <variation>N</variation>
    <location>
      <position position="162"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; no nucleotide entry." evidence="57" ref="1">
    <original>D</original>
    <variation>Y</variation>
    <location>
      <position position="370"/>
    </location>
  </feature>
  <feature type="strand" evidence="76">
    <location>
      <begin position="10"/>
      <end position="12"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="14"/>
      <end position="20"/>
    </location>
  </feature>
  <feature type="strand" evidence="75">
    <location>
      <begin position="32"/>
      <end position="44"/>
    </location>
  </feature>
  <feature type="strand" evidence="75">
    <location>
      <begin position="49"/>
      <end position="57"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="62"/>
      <end position="64"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="66"/>
      <end position="77"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="78"/>
      <end position="80"/>
    </location>
  </feature>
  <feature type="strand" evidence="75">
    <location>
      <begin position="86"/>
      <end position="94"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="98"/>
      <end position="110"/>
    </location>
  </feature>
  <feature type="strand" evidence="75">
    <location>
      <begin position="112"/>
      <end position="122"/>
    </location>
  </feature>
  <feature type="turn" evidence="75">
    <location>
      <begin position="124"/>
      <end position="127"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="129"/>
      <end position="138"/>
    </location>
  </feature>
  <feature type="strand" evidence="77">
    <location>
      <begin position="142"/>
      <end position="144"/>
    </location>
  </feature>
  <feature type="strand" evidence="75">
    <location>
      <begin position="147"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="154"/>
      <end position="164"/>
    </location>
  </feature>
  <feature type="helix" evidence="75">
    <location>
      <begin position="178"/>
      <end position="193"/>
    </location>
  </feature>
  <feature type="strand" evidence="70">
    <location>
      <begin position="195"/>
      <end position="197"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="199"/>
      <end position="206"/>
    </location>
  </feature>
  <feature type="helix" evidence="74">
    <location>
      <begin position="209"/>
      <end position="211"/>
    </location>
  </feature>
  <feature type="strand" evidence="69">
    <location>
      <begin position="213"/>
      <end position="217"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="219"/>
      <end position="228"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="231"/>
      <end position="234"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="236"/>
      <end position="238"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="240"/>
      <end position="243"/>
    </location>
  </feature>
  <feature type="strand" evidence="75">
    <location>
      <begin position="249"/>
      <end position="251"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="258"/>
      <end position="265"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="266"/>
      <end position="269"/>
    </location>
  </feature>
  <feature type="strand" evidence="71">
    <location>
      <begin position="273"/>
      <end position="275"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="277"/>
      <end position="285"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="289"/>
      <end position="301"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="305"/>
      <end position="313"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="318"/>
      <end position="320"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="321"/>
      <end position="330"/>
    </location>
  </feature>
  <feature type="strand" evidence="72">
    <location>
      <begin position="334"/>
      <end position="337"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="340"/>
      <end position="350"/>
    </location>
  </feature>
  <feature type="turn" evidence="73">
    <location>
      <begin position="353"/>
      <end position="355"/>
    </location>
  </feature>
  <feature type="helix" evidence="72">
    <location>
      <begin position="364"/>
      <end position="379"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU01083"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="2">
    <source>
      <dbReference type="PubMed" id="11863358"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="12167863"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="12808465"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="12808466"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="12809610"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="12859895"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="12970355"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="14527406"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="14528300"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="14528301"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="14557625"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="15031497"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="15054139"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="16378963"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="16418394"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="16527742"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="16699599"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="17020885"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="17121840"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="18288108"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="18667511"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="18836454"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="18842592"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="18849968"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="19153609"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="19458006"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="19887642"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="20219927"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="30">
    <source>
      <dbReference type="PubMed" id="20308164"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="31">
    <source>
      <dbReference type="PubMed" id="20335265"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="32">
    <source>
      <dbReference type="PubMed" id="20510315"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="33">
    <source>
      <dbReference type="PubMed" id="21123384"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="34">
    <source>
      <dbReference type="PubMed" id="21489586"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="35">
    <source>
      <dbReference type="PubMed" id="21659520"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="36">
    <source>
      <dbReference type="PubMed" id="21835787"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="37">
    <source>
      <dbReference type="PubMed" id="22190037"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="38">
    <source>
      <dbReference type="PubMed" id="22301159"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="39">
    <source>
      <dbReference type="PubMed" id="22791714"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="40">
    <source>
      <dbReference type="PubMed" id="22807680"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="41">
    <source>
      <dbReference type="PubMed" id="22915799"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="42">
    <source>
      <dbReference type="PubMed" id="23001005"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="43">
    <source>
      <dbReference type="PubMed" id="23097438"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="44">
    <source>
      <dbReference type="PubMed" id="23152537"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="45">
    <source>
      <dbReference type="PubMed" id="23300442"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="46">
    <source>
      <dbReference type="PubMed" id="25542899"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="47">
    <source>
      <dbReference type="PubMed" id="31253590"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="48">
    <source>
      <dbReference type="PubMed" id="31397674"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="49">
    <source>
      <dbReference type="PubMed" id="31792451"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="50">
    <source>
      <dbReference type="PubMed" id="36754086"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="51">
    <source>
      <dbReference type="PubMed" id="37419875"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="52">
    <source ref="5"/>
  </evidence>
  <evidence type="ECO:0000303" key="53">
    <source>
      <dbReference type="PubMed" id="14557625"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="54">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="55">
    <source>
      <dbReference type="PubMed" id="18448976"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="56">
    <source>
      <dbReference type="PubMed" id="18667511"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="57"/>
  <evidence type="ECO:0000305" key="58">
    <source>
      <dbReference type="PubMed" id="19887642"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="59">
    <source>
      <dbReference type="PubMed" id="23318957"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="60">
    <source>
      <dbReference type="PubMed" id="31253590"/>
    </source>
  </evidence>
  <evidence type="ECO:0000312" key="61">
    <source>
      <dbReference type="HGNC" id="HGNC:17357"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="62">
    <source>
      <dbReference type="PDB" id="4ROV"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="63">
    <source>
      <dbReference type="PDB" id="4ROW"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="64">
    <source>
      <dbReference type="PDB" id="8CX0"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="65">
    <source>
      <dbReference type="PDB" id="8CX1"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="66">
    <source>
      <dbReference type="PDB" id="8CX2"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="67">
    <source>
      <dbReference type="PDB" id="8H0I"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="68">
    <source>
      <dbReference type="PDB" id="8J62"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="69">
    <source>
      <dbReference type="PDB" id="2JYW"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="70">
    <source>
      <dbReference type="PDB" id="2KBO"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="71">
    <source>
      <dbReference type="PDB" id="3E1U"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="72">
    <source>
      <dbReference type="PDB" id="3V4K"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="73">
    <source>
      <dbReference type="PDB" id="6K3J"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="74">
    <source>
      <dbReference type="PDB" id="6K3K"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="75">
    <source>
      <dbReference type="PDB" id="8CX0"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="76">
    <source>
      <dbReference type="PDB" id="8CX1"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="77">
    <source>
      <dbReference type="PDB" id="8CX2"/>
    </source>
  </evidence>
  <sequence length="384" mass="46408" checksum="60525DC3B7D903D6" modified="2001-03-01" version="1">MKPHFRNTVERMYRDTFSYNFYNRPILSRRNTVWLCYEVKTKGPSRPPLDAKIFRGQVYSELKYHPEMRFFHWFSKWRKLHRDQEYEVTWYISWSPCTKCTRDMATFLAEDPKVTLTIFVARLYYFWDPDYQEALRSLCQKRDGPRATMKIMNYDEFQHCWSKFVYSQRELFEPWNNLPKYYILLHIMLGEILRHSMDPPTFTFNFNNEPWVRGRHETYLCYEVERMHNDTWVLLNQRRGFLCNQAPHKHGFLEGRHAELCFLDVIPFWKLDLDQDYRVTCFTSWSPCFSCAQEMAKFISKNKHVSLCIFTARIYDDQGRCQEGLRTLAEAGAKISIMTYSEFKHCWDTFVDHQGCPFQPWDGLDEHSQDLSGRLRAILQNQEN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>